This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
mental health | 985 |
united states | 850 |
young children | 827 |
respiratory tract | 804 |
risk factors | 624 |
pediatric patients | 616 |
health care | 589 |
acute respiratory | 581 |
among children | 510 |
intensive care | 495 |
systematic review | 453 |
respiratory syncytial | 447 |
children aged | 443 |
lower respiratory | 440 |
syncytial virus | 436 |
mean age | 433 |
mg kg | 421 |
years old | 421 |
case report | 374 |
public health | 371 |
bone marrow | 348 |
respiratory infections | 334 |
infectious diseases | 334 |
coronavirus disease | 323 |
design method | 318 |
renal failure | 310 |
severe acute | 308 |
doc id | 302 |
cord uid | 302 |
significantly higher | 294 |
otitis media | 293 |
respiratory syndrome | 292 |
acquired pneumonia | 292 |
tract infections | 286 |
respiratory viruses | 285 |
upper respiratory | 285 |
increased risk | 284 |
renal function | 278 |
control group | 278 |
may also | 273 |
streptococcus pneumoniae | 265 |
viral infections | 263 |
tract infection | 263 |
statistically significant | 262 |
lung function | 262 |
clinical features | 261 |
median age | 261 |
mechanical ventilation | 261 |
older children | 255 |
care unit | 255 |
child health | 253 |
age group | 252 |
nephrotic syndrome | 252 |
world health | 251 |
risk factor | 248 |
respiratory distress | 247 |
high risk | 245 |
lung disease | 244 |
novel coronavirus | 242 |
cohort study | 240 |
one patient | 239 |
blood pressure | 238 |
significant difference | 234 |
health organization | 230 |
least one | 220 |
age groups | 212 |
early childhood | 210 |
palliative care | 209 |
developing countries | 209 |
controlled trial | 208 |
respiratory failure | 208 |
infected children | 207 |
pediatric population | 205 |
clinical characteristics | 204 |
mg dl | 203 |
urinary tract | 203 |
side effects | 199 |
significant differences | 199 |
healthy children | 199 |
influenza virus | 199 |
kg day | 192 |
online learning | 186 |
immune response | 186 |
hospitalized children | 184 |
cystic fibrosis | 183 |
viral infection | 182 |
child care | 181 |
respiratory symptoms | 179 |
renal disease | 178 |
child abuse | 178 |
heart disease | 177 |
kidney disease | 176 |
present study | 175 |
bacterial pneumonia | 175 |
imaging findings | 175 |
immune system | 173 |
young people | 169 |
methods materials | 168 |
children may | 168 |
nervous system | 167 |
ml min | 167 |
children younger | 167 |
pneumococcal conjugate | 165 |
physical examination | 165 |
two groups | 164 |
virus infection | 164 |
prospective study | 162 |
long term | 162 |
respiratory infection | 162 |
severe disease | 160 |
measles virus | 158 |
emergency department | 158 |
differential diagnosis | 157 |
severe pneumonia | 157 |
age years | 155 |
important role | 154 |
significantly lower | 153 |
fi rst | 153 |
abdominal pain | 153 |
chain reaction | 153 |
pneumococcal pneumonia | 152 |
physical activity | 151 |
renal biopsy | 151 |
bacterial infection | 149 |
polymerase chain | 149 |
states background | 148 |
health problems | 147 |
two patients | 147 |
clinical course | 147 |
mortality rate | 147 |
young adults | 147 |
ng ml | 147 |
heart failure | 146 |
congenital heart | 146 |
critically ill | 146 |
clinical practice | 145 |
family members | 145 |
sickle cell | 145 |
health services | 145 |
new york | 145 |
allergic rhinitis | 144 |
computed tomography | 144 |
disease severity | 143 |
aged years | 142 |
clinical presentation | 141 |
epithelial cells | 141 |
stem cell | 141 |
higher risk | 139 |
retrospective study | 139 |
disease control | 139 |
childhood pneumonia | 138 |
case series | 137 |
family history | 137 |
children hospitalized | 136 |
adult patients | 136 |
may occur | 136 |
first year | 136 |
blood cell | 136 |
magnetic resonance | 135 |
one year | 135 |
common cause | 134 |
child maltreatment | 134 |
bacterial infections | 134 |
informed consent | 134 |
child welfare | 133 |
haemophilus influenzae | 133 |
primary care | 130 |
conjugate vaccine | 130 |
human bocavirus | 130 |
chest radiographs | 129 |
human metapneumovirus | 129 |
antibiotic therapy | 129 |
social distancing | 128 |
child protection | 128 |
factors associated | 127 |
viral load | 127 |
birth weight | 126 |
escherichia coli | 126 |
domestic violence | 126 |
significantly associated | 125 |
pediatric intensive | 125 |
serum creatinine | 125 |
medical center | 124 |
middle ear | 124 |
less likely | 124 |
old girl | 124 |
south africa | 123 |
central nervous | 123 |
data collection | 122 |
peripheral blood | 122 |
clinical trial | 122 |
per day | 122 |
blood cultures | 121 |
adverse events | 121 |
chest radiograph | 121 |
randomized controlled | 120 |
patients received | 119 |
rotavirus infection | 119 |
year old | 119 |
pulmonary function | 118 |
social workers | 117 |
logistic regression | 116 |
younger children | 116 |
somatic dysfunction | 116 |
influenza vaccine | 115 |
clinical trials | 115 |
may result | 115 |
previous studies | 115 |
medical records | 114 |
children years | 113 |
clinical symptoms | 113 |
reactive protein | 113 |
airway obstruction | 113 |
current study | 112 |
injury behavior | 111 |
children less | 111 |
study period | 111 |
pregnant women | 111 |
upper airway | 111 |
high levels | 111 |
sample size | 110 |
hiv infection | 110 |
old boy | 108 |
high school | 108 |
refugee children | 108 |
childhood asthma | 108 |
sore throat | 108 |
renal transplantation | 108 |
distress syndrome | 107 |
respiratory disease | 107 |
chronic cough | 107 |
general population | 107 |
school closures | 107 |
sex offenders | 107 |
clinical manifestations | 106 |
immune responses | 106 |
health outcomes | 105 |
soft tissue | 105 |
cell disease | 105 |
hearing loss | 105 |
spinal cord | 105 |
oxygen saturation | 105 |
severe covid | 105 |
food allergy | 105 |
air pollution | 104 |
preschool children | 103 |
chronic renal | 103 |
may help | 102 |
income countries | 101 |
white blood | 101 |
gene expression | 101 |
one study | 101 |
weight loss | 101 |
chest ct | 100 |
two years | 100 |
young infants | 100 |
dental caries | 100 |
child policy | 100 |
respiratory illness | 99 |
study group | 99 |
high prevalence | 99 |
nitric oxide | 99 |
lymph nodes | 99 |
stage renal | 99 |
ill children | 98 |
staphylococcus aureus | 98 |
one child | 98 |
pg ml | 98 |
see table | 98 |
blood culture | 98 |
psychological distress | 98 |
year period | 98 |
university hospital | 98 |
children admitted | 98 |
ct scan | 97 |
pulmonary disease | 97 |
bronchoalveolar lavage | 97 |
several studies | 96 |
viral pneumonia | 96 |
inflammatory syndrome | 96 |
atopic dermatitis | 96 |
may lead | 96 |
retrospective review | 96 |
rsv infection | 96 |
time pcr | 95 |
human rights | 95 |
resonance imaging | 94 |
also found | 94 |
inclusion criteria | 94 |
mr imaging | 93 |
performed using | 92 |
specific ige | 92 |
transplant recipients | 92 |
united kingdom | 91 |
children without | 91 |
less common | 91 |
significantly increased | 91 |
adverse effects | 90 |
liver oil | 90 |
three patients | 90 |
old children | 90 |
many children | 90 |
infl uenza | 90 |
chronic kidney | 89 |
white matter | 89 |
antibiotic treatment | 89 |
may cause | 88 |
severe cases | 88 |
will also | 87 |
chart review | 87 |
acute lower | 87 |
children presenting | 87 |
confidence interval | 87 |
kidney injury | 86 |
per year | 86 |
child attachment | 86 |
commonly used | 86 |
early diagnosis | 86 |
pediatric oncology | 86 |
gestational age | 86 |
severe asthma | 86 |
kawasaki disease | 85 |
critical care | 85 |
medical care | 85 |
common cold | 85 |
cod liver | 85 |
infectious disease | 85 |
respiratory virus | 85 |
mycoplasma pneumoniae | 84 |
significantly different | 84 |
respiratory pathogens | 84 |
syndrome coronavirus | 84 |
cell count | 84 |
heart rate | 84 |
coronavirus infection | 83 |
treatment group | 83 |
technology use | 83 |
first years | 83 |
clinical improvement | 83 |
body mass | 83 |
signifi cant | 83 |
hospital admission | 83 |
five years | 83 |
peritoneal dialysis | 83 |
indigenous children | 83 |
renal transplant | 82 |
statistical analysis | 81 |
healthy controls | 81 |
clinical data | 81 |
asymptomatic children | 81 |
natural history | 81 |
term follow | 81 |
influenza infection | 81 |
tertiary care | 81 |
multiple sclerosis | 81 |
acute bronchiolitis | 80 |
autism spectrum | 80 |
predictive value | 80 |
hospital stay | 80 |
birth cohort | 80 |
respiratory viral | 80 |
viral respiratory | 80 |
age range | 80 |
screen time | 79 |
four patients | 79 |
hong kong | 79 |
two cases | 79 |
sectional study | 79 |
bacterial pathogens | 79 |
blood cells | 79 |
pandemic influenza | 79 |
leading cause | 78 |
school children | 78 |
glomerular filtration | 78 |
social isolation | 78 |
recent years | 78 |
pleural effusion | 78 |
pneumococcal disease | 78 |
pediatric infectious | 78 |
influenzae type | 78 |
may contribute | 77 |
two children | 77 |
care units | 77 |
even though | 77 |
temporal bone | 77 |
chest radiography | 77 |
patients without | 77 |
pediatric nephrology | 77 |
severe illness | 77 |
acute renal | 77 |
respiratory support | 77 |
airway inflammation | 76 |
vertical transmission | 76 |
health system | 76 |
acute otitis | 76 |
cell lines | 76 |
literature review | 76 |
case reports | 76 |
school students | 76 |
th percentile | 75 |
within hours | 75 |
longitudinal study | 75 |
recent studies | 75 |
marrow transplantation | 75 |
year follow | 75 |
control study | 75 |
obese children | 75 |
nutritional status | 75 |
odds ratio | 74 |
acute kidney | 74 |
fl uid | 74 |
severe respiratory | 74 |
health status | 74 |
seasonal influenza | 74 |
pilot study | 74 |
fi bers | 74 |
respiratory rate | 74 |
preterm infants | 73 |
data suggest | 73 |
five patients | 73 |
human immunodeficiency | 73 |
mass index | 73 |
multisystem inflammatory | 73 |
determine whether | 73 |
substance use | 73 |
old male | 72 |
mortality rates | 72 |
children living | 72 |
one case | 72 |
immunodeficiency virus | 72 |
developed countries | 72 |
like illness | 72 |
study conducted | 71 |
socioeconomic status | 71 |
clinical signs | 71 |
old female | 71 |
gastrointestinal tract | 71 |
asthmatic children | 71 |
randomized trial | 71 |
class ii | 71 |
hiv aids | 71 |
analysis showed | 71 |
first months | 71 |
average age | 71 |
patients treated | 70 |
cerebral palsy | 70 |
american academy | 70 |
patients aged | 70 |
interstitial lung | 70 |
gold standard | 70 |
pneumococcal carriage | 70 |
findings suggest | 70 |
retrospective chart | 70 |
filtration rate | 70 |
blood samples | 70 |
confirmed cases | 70 |
paediatric patients | 69 |
study showed | 69 |
wide range | 69 |
ml kg | 69 |
uric acid | 69 |
neonatal period | 69 |
incubation period | 69 |
care needs | 69 |
coping style | 69 |
asthma control | 69 |
copyright holder | 69 |
oral health | 69 |
febrile seizures | 69 |
clinical outcomes | 69 |
observational study | 69 |
invasive pneumococcal | 69 |
red blood | 69 |
clinical management | 69 |
study found | 69 |
health professionals | 68 |
social media | 68 |
patients receiving | 68 |
parainfluenza virus | 68 |
care providers | 68 |
influenza viruses | 68 |
national health | 68 |
medical conditions | 68 |
significantly reduced | 68 |
pediatric radiology | 68 |
lung injury | 68 |
urinary protein | 67 |
results suggest | 67 |
cd cd | 67 |
complete remission | 67 |
foreign body | 67 |
antimicrobial therapy | 67 |
severe combined | 67 |
allergic diseases | 67 |
flow cytometry | 67 |
viral etiology | 67 |
chronic lung | 66 |
may play | 66 |
children will | 66 |
spectrum disorder | 66 |
among patients | 66 |
renal tubular | 66 |
body weight | 66 |
left ventricular | 66 |
developmental delay | 65 |
standard deviation | 65 |
made available | 65 |
depressive symptoms | 65 |
gastrointestinal symptoms | 65 |
aged children | 65 |
future research | 65 |
end stage | 65 |
ige levels | 65 |
premature infants | 65 |
pediatric patient | 64 |
higher levels | 64 |
iga nephropathy | 64 |
autosomal recessive | 64 |
six months | 64 |
function tests | 64 |
identifi ed | 64 |
statistical significance | 64 |
platelet count | 64 |
aged months | 64 |
nasopharyngeal swabs | 64 |
infl ammation | 63 |
within days | 63 |
granted medrxiv | 63 |
author funder | 63 |
hospitalized patients | 63 |
nucleic acid | 63 |
influenza vaccination | 63 |
syrian refugee | 63 |
recurrent wheezing | 63 |
virus infections | 63 |
previously reported | 63 |
normal range | 63 |
high mortality | 63 |
global health | 62 |
study design | 62 |
radiation dose | 62 |
widely used | 62 |
previously described | 62 |
converting enzyme | 62 |
combined immunodeficiency | 62 |
care services | 62 |
recent study | 62 |
septic shock | 62 |
study population | 62 |
study aimed | 62 |
respiratory diseases | 62 |
intervention group | 62 |
see chapter | 62 |
diagnostic criteria | 61 |
may include | 61 |
major cause | 61 |
mean duration | 61 |
blood transfusion | 61 |
acute lymphoblastic | 61 |
regression analysis | 61 |
early life | 61 |
social work | 61 |
day care | 61 |
version posted | 61 |
child development | 61 |
asthma exacerbations | 61 |
environmental factors | 61 |
lymphoblastic leukemia | 61 |
secondary bacterial | 61 |
replacement therapy | 60 |
lung diseases | 60 |
significant correlation | 60 |
disease progression | 60 |
antibiotic use | 60 |
drug administration | 60 |
significant association | 60 |
higher rates | 60 |
measles vaccine | 60 |
ct scans | 60 |
six patients | 60 |
liver disease | 60 |
previously healthy | 60 |
tympanic membrane | 59 |
per week | 59 |
th century | 59 |
infl ammatory | 59 |
viral pathogens | 59 |
job loss | 59 |
hematopoietic stem | 59 |
randomised controlled | 59 |
laboratory tests | 59 |
nocturnal enuresis | 59 |
family leave | 59 |
paid family | 58 |
tested positive | 58 |
controlled trials | 58 |
oral cavity | 58 |
cervical spine | 58 |
disease activity | 58 |
sleep apnea | 58 |
may present | 58 |
south african | 58 |
laboratory findings | 58 |
clinical diagnosis | 58 |
hypertonic saline | 58 |
months old | 58 |
based study | 57 |
united nations | 57 |
specialist palliative | 57 |
immunocompromised patients | 57 |
data analysis | 57 |
studies suggest | 57 |
important cause | 57 |
renal insufficiency | 57 |
nk cells | 57 |
cell transplantation | 57 |
last years | 57 |
social services | 57 |
viral bronchiolitis | 57 |
welfare workers | 57 |
juvenile idiopathic | 57 |
prospective studies | 57 |
test results | 56 |
oxygen therapy | 56 |
physical health | 56 |
prospective cohort | 56 |
practice guidelines | 56 |
allergic disease | 56 |
patients may | 56 |
parainfluenza viruses | 56 |
patients showed | 56 |
low dose | 56 |
cell transplant | 56 |
acute phase | 56 |
one third | 56 |
cranial base | 56 |
infection control | 56 |
antibiotic resistance | 56 |
supportive care | 56 |
image quality | 56 |
analyzed using | 56 |
valent pneumococcal | 55 |
breast milk | 55 |
severe complications | 55 |
underlying disease | 55 |
antimicrobial resistance | 55 |
children whose | 55 |
urban areas | 55 |
cardiovascular disease | 55 |
acute rejection | 55 |
disease burden | 55 |
parents reported | 55 |
significant increase | 55 |
two weeks | 55 |
radiographic findings | 55 |
primary school | 55 |
bacterial meningitis | 55 |
retrospective cohort | 54 |
oncology patients | 54 |
significantly decreased | 54 |
cardiac surgery | 54 |
weight gain | 54 |
influenza pandemic | 54 |
decision making | 54 |
pediatr radiol | 54 |
fetal mri | 54 |
total number | 54 |
electron microscopy | 54 |
diagnostic accuracy | 54 |
one month | 54 |
community health | 54 |
large number | 54 |
serious bacterial | 54 |
idiopathic arthritis | 54 |
high frequency | 53 |
positive results | 53 |
nasal obstruction | 53 |
within months | 53 |
human coronavirus | 53 |
community acquired | 53 |
authors declare | 53 |
influenza season | 53 |
kidney transplantation | 53 |
renal involvement | 53 |
like symptoms | 53 |
febrile infants | 53 |
saharan africa | 53 |
small number | 53 |
saudi arabia | 53 |
children infected | 53 |
newly diagnosed | 53 |
retrospective analysis | 53 |
uninfected children | 53 |
rsv bronchiolitis | 53 |
nasal congestion | 53 |
nasal cavity | 53 |
high fever | 53 |
smooth muscle | 53 |
diarrheal disease | 53 |
well tolerated | 52 |
febrile children | 52 |
included children | 52 |
drug use | 52 |
will provide | 52 |
paternity leave | 52 |
higher incidence | 52 |
school closure | 52 |
substance misuse | 52 |
emotional coping | 52 |
previous research | 52 |
acute diarrhea | 52 |
airway pressure | 52 |
positive correlation | 52 |
paediatric palliative | 52 |
emergency departments | 52 |
metabolic acidosis | 52 |
retrospectively reviewed | 52 |
total ige | 52 |
negative affect | 52 |
wheezing episode | 52 |
three times | 51 |
breast feeding | 51 |
inflammatory response | 51 |
online survey | 51 |
affected children | 51 |
health problem | 51 |
patients underwent | 51 |
avian influenza | 51 |
infection may | 51 |
will need | 51 |
peer review | 51 |
months later | 51 |
low birth | 51 |
north america | 51 |
children receiving | 51 |
low levels | 51 |
immunocompromised children | 51 |
dust mite | 51 |
brain injury | 51 |
less severe | 51 |
diagnostic tests | 51 |
pulmonary hypertension | 51 |
fi ndings | 51 |
growth factor | 50 |
social support | 50 |
vulnerable children | 50 |
first case | 50 |
negative emotion | 50 |
imaging features | 50 |
health needs | 50 |
patients diagnosed | 50 |
group i | 50 |
may require | 50 |
fatty acids | 50 |
future studies | 50 |
segmental glomerulosclerosis | 50 |
significant reduction | 50 |
international license | 50 |
york city | 50 |
inhaled corticosteroids | 50 |
also reported | 50 |
significant risk | 50 |
older adults | 50 |
inflammatory markers | 50 |
soft palate | 50 |
ionizing radiation | 50 |
vesicoureteral reflux | 50 |
bacterial tracheitis | 50 |
physical abuse | 50 |
laboratory data | 50 |
frontal bone | 49 |
graft function | 49 |
past years | 49 |
pediatric cases | 49 |
three children | 49 |
among infants | 49 |
viral replication | 49 |
childhood cancer | 49 |
radiation exposure | 49 |
term outcome | 49 |
protective factors | 49 |
much higher | 49 |
often associated | 49 |
pediatric emergency | 49 |
evidence suggests | 49 |
ethics committee | 49 |
hospital admissions | 49 |
special needs | 49 |
innate immune | 49 |
children treated | 49 |
house dust | 49 |
median time | 49 |
high rates | 49 |
greater risk | 49 |
will help | 49 |
temporal bones | 49 |
respiratory illnesses | 49 |
task force | 48 |
descriptive statistics | 48 |
organ failure | 48 |
clinically significant | 48 |
common causes | 48 |
amino acid | 48 |
among adults | 48 |
pleural effusions | 48 |
children enrolled | 48 |
genetic testing | 48 |
first time | 48 |
clinical findings | 48 |
blood flow | 48 |
brain mri | 48 |
may provide | 48 |
lung biopsy | 48 |
will discuss | 48 |
type i | 47 |
exclusion criteria | 47 |
sexual abuse | 47 |
maternity leave | 47 |
paranasal sinuses | 47 |
bronchopulmonary dysplasia | 47 |
diffi cult | 47 |
patients undergoing | 47 |
developmental disabilities | 47 |
recurrent respiratory | 47 |
early intervention | 47 |
multivariate analysis | 47 |
point scale | 47 |
low risk | 47 |
health promotion | 47 |
childhood obesity | 47 |
time period | 47 |
autosomal dominant | 47 |
patients admitted | 47 |
demographic characteristics | 47 |
intravenous immunoglobulin | 46 |
campylobacter jejuni | 46 |
imaging modalities | 46 |
neonatal intensive | 46 |
nine patients | 46 |
another study | 46 |
mental disorders | 46 |
may need | 46 |
obstructive sleep | 46 |
ct imaging | 46 |
better understanding | 46 |
allergic patients | 46 |
adopted children | 46 |
pneumococcal proteins | 46 |
attack rates | 46 |
high resolution | 46 |
negative impact | 46 |
high grade | 46 |
high dose | 46 |
otherwise healthy | 46 |
syrian refugees | 46 |
cell proliferation | 46 |
diseases society | 46 |
lower airways | 46 |
chronic obstructive | 46 |
pulse oximetry | 46 |
acute viral | 46 |
cord blood | 46 |
emotion regulation | 46 |
uremic syndrome | 46 |
multiplex pcr | 46 |
transplant patients | 46 |
chronic diseases | 45 |
may increase | 45 |
three months | 45 |
health crisis | 45 |
measured using | 45 |
high incidence | 45 |
service delivery | 45 |
medrxiv preprint | 45 |
pediatric radiologists | 45 |
creatinine clearance | 45 |
systematic reviews | 45 |
fl exion | 45 |
icu admission | 45 |
treatment groups | 45 |
patient population | 45 |
chronic respiratory | 45 |
human rhinovirus | 45 |
respiratory system | 45 |
medical complexity | 45 |
coping strategies | 45 |
asthma symptoms | 45 |
clinical picture | 45 |
significant decrease | 45 |
clinical examination | 45 |
month period | 44 |
single dose | 44 |
disease onset | 44 |
treatment options | 44 |
emergency room | 44 |
allergic sensitization | 44 |
nasopharyngeal aspirates | 44 |
group ii | 44 |
igg als | 44 |
european countries | 44 |
central venous | 44 |
specialist paediatric | 44 |
human milk | 44 |
mri brain | 44 |
focal segmental | 44 |
cerebrospinal fluid | 44 |
close contact | 44 |
care workers | 44 |
graft survival | 44 |
camh services | 44 |
pediatric renal | 44 |
emotional regulation | 44 |
odds ratios | 44 |
effective treatment | 44 |
pcr assays | 44 |
conjugate vaccines | 44 |
health conditions | 44 |
small children | 44 |
patients presented | 44 |
study included | 44 |
first days | 44 |
children compared | 44 |
measles vaccination | 44 |
ill patients | 44 |
vast majority | 44 |
urine samples | 44 |
linear regression | 44 |
ct findings | 44 |
biopsy showed | 44 |
aged less | 44 |
human services | 44 |
dmsa scan | 43 |
medical management | 43 |
associated pneumonia | 43 |
may develop | 43 |
care system | 43 |
asthma exacerbation | 43 |
upper thoracic | 43 |
tobacco smoke | 43 |
better understand | 43 |
attack rate | 43 |
imaging studies | 43 |
lower airway | 43 |
viral loads | 43 |
animal models | 43 |
stress disorder | 43 |
refl ex | 43 |
rotavirus infections | 43 |
monoclonal antibody | 43 |
psychological well | 43 |
pediatric hematology | 43 |
primary immunodeficiency | 43 |
control measures | 43 |
steroid therapy | 43 |
overall survival | 43 |
brachial plexus | 43 |
nasal swabs | 43 |
three groups | 43 |
written informed | 43 |
blood count | 43 |
health service | 43 |
children received | 43 |
complete blood | 43 |
age months | 43 |
school age | 42 |
pediatric covid | 42 |
bronchiolitis obliterans | 42 |
risk children | 42 |
many cases | 42 |
head trauma | 42 |
cohort studies | 42 |
multicenter study | 42 |
may become | 42 |
patients developed | 42 |
child may | 42 |
also showed | 42 |
pneumonia etiology | 42 |
renal replacement | 42 |
median duration | 42 |
imaging techniques | 42 |
limited data | 42 |
eff ect | 42 |
oxidative stress | 42 |
cardiac output | 42 |
global burden | 42 |
primary outcome | 42 |
study will | 42 |
protective effect | 42 |
serum levels | 42 |
clinical care | 42 |
outcome measures | 42 |
early onset | 42 |
healthcare services | 42 |
health centre | 42 |
infant mortality | 42 |
chronic disease | 42 |
chest wall | 42 |
may represent | 42 |
psychological impact | 42 |
older age | 42 |
per patient | 42 |
pneumonia cases | 41 |
clinical presentations | 41 |
well known | 41 |
middle east | 41 |
household contacts | 41 |
median follow | 41 |
vascular malformations | 41 |
early detection | 41 |
young age | 41 |
pediatric cancer | 41 |
two months | 41 |
antibody response | 41 |
sex offender | 41 |
demographic data | 41 |
human coronaviruses | 41 |
clinical outcome | 41 |
poor prognosis | 41 |
assessed using | 41 |
among hospitalized | 41 |
seven patients | 41 |
child relationship | 41 |
children older | 41 |
obstructive pulmonary | 41 |
respiratory samples | 41 |
results showed | 41 |
new zealand | 41 |
nurturing care | 41 |
wilms tumor | 41 |
first week | 41 |
acute asthma | 41 |
cell death | 41 |
last year | 41 |
two different | 41 |
status epilepticus | 41 |
induced wheezing | 41 |
three years | 41 |
iron overload | 41 |
springer nature | 41 |
mg day | 41 |
age children | 41 |
child mortality | 40 |
much less | 40 |
mental illness | 40 |
parents may | 40 |
controlled study | 40 |
disease course | 40 |
marrow transplant | 40 |
results indicate | 40 |
renal diseases | 40 |
conjugate vaccination | 40 |
cytokine storm | 40 |
lymph node | 40 |
nasopharyngeal carriage | 40 |
strongly associated | 40 |
working group | 40 |
patients presenting | 40 |
clinical significance | 40 |
hemolytic anemia | 40 |
graft failure | 40 |
health insurance | 40 |
perceived stress | 40 |
high level | 40 |
mrna expression | 40 |
will require | 40 |
class i | 40 |
mental status | 40 |
several days | 40 |
states department | 40 |
requiring hospitalization | 40 |
may affect | 40 |
acute gastroenteritis | 40 |
included patients | 40 |
survival rates | 40 |
analysis revealed | 40 |
different types | 40 |
children undergoing | 39 |
posterior fossa | 39 |
adolescent mental | 39 |
less frequent | 39 |
traumatic stress | 39 |
infants younger | 39 |
viral gastroenteritis | 39 |
eight patients | 39 |
lupus nephritis | 39 |
elementary school | 39 |
copies ml | 39 |
mean difference | 39 |
bronchial asthma | 39 |
placebo group | 39 |
antibody responses | 39 |
hyoid bone | 39 |
stem cells | 39 |
children diagnosed | 39 |
parental substance | 39 |
may reduce | 39 |
group differences | 39 |
supplemental oxygen | 39 |
nasal cavities | 39 |
health systems | 39 |
antiviral treatment | 39 |
relatively low | 39 |
typhoid fever | 39 |
closely related | 39 |
less frequently | 39 |
shiga toxin | 39 |
health survey | 39 |
ckd stage | 39 |
similar results | 39 |
food insecurity | 39 |
viral shedding | 39 |
paid maternity | 39 |
gas exchange | 39 |
skin test | 39 |
study participants | 38 |
influenza transmission | 38 |
significant improvement | 38 |
law enforcement | 38 |
communication skills | 38 |
six children | 38 |
hand hygiene | 38 |
poor outcome | 38 |
care team | 38 |
exact test | 38 |
one week | 38 |
th day | 38 |
chronic diarrhea | 38 |
current situation | 38 |
stress symptoms | 38 |
rights reserved | 38 |
children born | 38 |
poster sessions | 38 |
pulmonary fibrosis | 38 |
health issues | 38 |
hemolytic uremic | 38 |
care centers | 38 |
interquartile range | 38 |
bloody diarrhea | 38 |
endotracheal intubation | 38 |
aspiration pneumonia | 38 |
four children | 38 |
chest pain | 38 |
weeks gestation | 38 |
univariate analysis | 38 |
bacterial bronchitis | 38 |
hospitalized infants | 38 |
epidemiologic studies | 38 |
family member | 38 |
renal allograft | 38 |
first line | 38 |
basement membrane | 38 |
included studies | 38 |
creatinine ratio | 38 |
health effects | 38 |
many countries | 38 |
immune function | 38 |
rural areas | 38 |
frequently associated | 37 |
high rate | 37 |
internationally adopted | 37 |
african american | 37 |
global child | 37 |
small bowel | 37 |
alport syndrome | 37 |
two studies | 37 |
studies conducted | 37 |
extremely rare | 37 |
clinical severity | 37 |
death drive | 37 |
pleural fluid | 37 |
also occur | 37 |
induction therapy | 37 |
control groups | 37 |
may explain | 37 |
tract disease | 37 |
arterial blood | 37 |
fatty liver | 37 |
parainfl uenza | 37 |
healthy infants | 37 |
policy makers | 37 |
endothelial cells | 37 |
growth retardation | 37 |
first hours | 37 |
data collected | 37 |
preliminary results | 37 |
solid tumors | 37 |
pet ct | 37 |
chronic suppurative | 37 |
coronary artery | 37 |
well established | 37 |
type diabetes | 37 |
cd cells | 37 |
mri findings | 37 |
australian children | 37 |
adverse outcomes | 37 |
renal dysfunction | 37 |
paediatric intensive | 37 |
common symptoms | 37 |
western blot | 37 |
pediatric age | 36 |
study also | 36 |
incidence rate | 36 |
watery diarrhea | 36 |
medical history | 36 |
randomized clinical | 36 |
criminal justice | 36 |
severely ill | 36 |
health workers | 36 |
least months | 36 |
parenting stress | 36 |
healthcare providers | 36 |
higher prevalence | 36 |
pulmonary tuberculosis | 36 |
study entry | 36 |
recurrent infections | 36 |
commercially available | 36 |
potential risk | 36 |
reported cases | 36 |
diabetes mellitus | 36 |
infants born | 36 |
infl uence | 36 |
carbon monoxide | 36 |
connective tissue | 36 |
may show | 36 |
serum albumin | 36 |
protein excretion | 36 |
inflammatory bowel | 36 |
children attending | 36 |
whole body | 36 |
infi ltrates | 36 |
years ago | 36 |
case presentation | 36 |
institutional review | 36 |
viral croup | 36 |
different age | 36 |
lumbar puncture | 36 |
longer duration | 36 |
disease may | 36 |
surface area | 36 |
confidence intervals | 36 |
common among | 36 |
gastroesophageal reflux | 36 |
hyperactivity disorder | 36 |
acute infection | 36 |
pulmonary infections | 36 |
imaging modality | 36 |
data will | 36 |
among young | 36 |
respiratory secretions | 35 |
month old | 35 |
lung parenchyma | 35 |
may improve | 35 |
gram stain | 35 |
corpus callosum | 35 |
cell surface | 35 |
moraxella catarrhalis | 35 |
children using | 35 |
among parents | 35 |
endotracheal tube | 35 |
environmental footprints | 35 |
first trial | 35 |
animal abuse | 35 |
solid organ | 35 |
chronic conditions | 35 |
viral rna | 35 |
term effects | 35 |
remains unclear | 35 |
hiv infected | 35 |
vascular anomalies | 35 |
asthma patients | 35 |
compared using | 35 |
related pneumonia | 35 |
electronic medical | 35 |
surgical resection | 35 |
intended use | 35 |
data regarding | 35 |
pcr assay | 35 |
physical aggression | 35 |
mycophenolate mofetil | 35 |
many patients | 35 |
response rate | 35 |
social care | 35 |
metabolic syndrome | 35 |
physical distancing | 35 |
behavioral problems | 35 |
research ethics | 35 |
positively correlated | 35 |
twice daily | 35 |
young adult | 35 |
home confinement | 35 |
also important | 35 |
studies showed | 35 |
epithelial cell | 35 |
acute igg | 35 |
peritonsillar abscess | 35 |
one hundred | 34 |
reverse transcriptase | 34 |
nasopharyngeal swab | 34 |
abuse potential | 34 |
survival rate | 34 |
barr virus | 34 |
previous reports | 34 |
infections among | 34 |
younger age | 34 |
may manifest | 34 |
sick children | 34 |
years later | 34 |
acute wheezing | 34 |
neutrophil count | 34 |
coronavirus infections | 34 |
children ages | 34 |
first month | 34 |
infectious agents | 34 |
infections caused | 34 |
mean follow | 34 |
significant effect | 34 |
many studies | 34 |
antimicrobial agents | 34 |
results show | 34 |
granulomatous disease | 34 |
bowel disease | 34 |
related complications | 34 |
positive airway | 34 |
significant impact | 34 |
medical treatment | 34 |
months post | 34 |
renal impairment | 34 |
clinical evaluation | 34 |
cases per | 34 |
range proteinuria | 34 |
wide variety | 34 |
significant morbidity | 34 |
patients infected | 34 |
clinical studies | 34 |
wheezing children | 34 |
critical illness | 34 |
liver function | 34 |
mononuclear cells | 34 |
fungal infections | 34 |
thoracic society | 34 |
including children | 34 |
bariatric surgery | 33 |
factors may | 33 |
normal values | 33 |
exome sequencing | 33 |
chest imaging | 33 |
published maps | 33 |
action sequence | 33 |
rhinovirus enterovirus | 33 |
total body | 33 |
least two | 33 |
vaccination coverage | 33 |
home education | 33 |
times higher | 33 |
increased susceptibility | 33 |
corticosteroid therapy | 33 |
virtual delivery | 33 |
live births | 33 |
red cell | 33 |
creative commons | 33 |
pulmonary artery | 33 |
among adolescents | 33 |
neuraminidase inhibitors | 33 |
significantly greater | 33 |
mouth breathing | 33 |
asthma prevalence | 33 |
multiplex real | 33 |
teaching points | 33 |
many years | 33 |
regression model | 33 |
care facilities | 33 |
weight management | 33 |
body temperature | 33 |
signifi cantly | 33 |
rotavirus gastroenteritis | 33 |
interstitial pneumonia | 33 |
cancer survivors | 33 |
adult population | 33 |
disease caused | 33 |
rapid review | 33 |
institutional affiliations | 33 |
nasal mucosa | 33 |
sars coronavirus | 33 |
myeloid leukemia | 33 |
well documented | 33 |
social problem | 33 |
air trapping | 33 |
opportunistic infections | 33 |
patient age | 33 |
stage i | 33 |
infection among | 33 |
wet cough | 33 |
negative emotions | 33 |
mass spectrometry | 33 |
symptomatic children | 33 |
sedimentation rate | 33 |
young child | 33 |
inflammatory process | 33 |
well siblings | 33 |
every day | 33 |
better prognosis | 32 |
positive blood | 32 |
renal damage | 32 |
cell function | 32 |
reference values | 32 |
febrile neutropenia | 32 |
hodgkin lymphoma | 32 |
table shows | 32 |
increased significantly | 32 |
new coronavirus | 32 |
severe infections | 32 |
radiation therapy | 32 |
children months | 32 |
real time | 32 |
fatty acid | 32 |
jurisdictional claims | 32 |
remains neutral | 32 |
liver biopsy | 32 |
urine culture | 32 |
children requiring | 32 |
negative predictive | 32 |
platelet counts | 32 |
mycobacterium tuberculosis | 32 |
gene mutation | 32 |
clinical history | 32 |
pulmonary infection | 32 |
last months | 32 |
host disease | 32 |
epidemiological features | 32 |
also may | 32 |
invasive disease | 32 |
nature remains | 32 |
research team | 32 |
critical role | 32 |
pulmonary vascular | 32 |
case study | 32 |
nosocomial infections | 32 |
clinical response | 32 |
cell culture | 32 |
one hand | 32 |
plasma exchange | 32 |
normal renal | 32 |
life care | 32 |
genome load | 32 |
dry cough | 32 |
asymptomatic infection | 32 |
alcohol misuse | 32 |
primary health | 32 |
suppurative lung | 32 |
latin america | 32 |
antiviral therapy | 32 |
american college | 32 |
refl ux | 32 |
presentation will | 32 |
pseudomonas aeruginosa | 32 |
parapneumonic effusions | 32 |
key role | 32 |
chronic granulomatous | 32 |
internal rotation | 32 |
medical record | 32 |
ece programs | 32 |
infected individuals | 31 |
wide spectrum | 31 |
acute lung | 31 |
toxic shock | 31 |
study using | 31 |
differential diagnoses | 31 |
rotavirus vaccine | 31 |
literature search | 31 |
may impact | 31 |
group compared | 31 |
children hospitalised | 31 |
children clinical | 31 |
diagnosed asthma | 31 |
kidney transplant | 31 |
grade iii | 31 |
important factor | 31 |
negative correlation | 31 |
mild disease | 31 |
renal scarring | 31 |
healthcare workers | 31 |
showed significant | 31 |
service providers | 31 |
study aims | 31 |
mean time | 31 |
model group | 31 |
single center | 31 |
deficit hyperactivity | 31 |
children showed | 31 |
widespread use | 31 |
weighted imaging | 31 |
significant changes | 31 |
three different | 31 |
children also | 31 |
case fatality | 31 |
healthcare professionals | 31 |
viral agents | 31 |
acute myeloid | 31 |
health research | 31 |
inner city | 31 |
previous study | 31 |
will continue | 31 |
common bacterial | 31 |
ill child | 31 |
pneumonia among | 31 |
risk populations | 31 |
small proportion | 31 |
health facilities | 31 |
high viral | 31 |
significant proportion | 31 |
time points | 31 |
renal injury | 31 |
lower levels | 31 |
multiple organ | 31 |
two decades | 31 |
short term | 31 |
blood volume | 30 |
bronchial reactivity | 30 |
care center | 30 |
early identification | 30 |
wheezing episodes | 30 |
fl attening | 30 |
drug users | 30 |
recurrent episodes | 30 |
foreign bodies | 30 |
care facility | 30 |
often present | 30 |
blood gas | 30 |
pcr tests | 30 |
appropriate treatment | 30 |
may benefit | 30 |
health information | 30 |
small intestine | 30 |
genetic analysis | 30 |
common respiratory | 30 |
first episode | 30 |
antigen detection | 30 |
urban health | 30 |
chinese parents | 30 |
several years | 30 |
brain tumors | 30 |
shock syndrome | 30 |
east respiratory | 30 |
patients died | 30 |
erythrocyte sedimentation | 30 |
protracted bacterial | 30 |
medical device | 30 |
oral antibiotics | 30 |
systematic analysis | 30 |
initial presentation | 30 |
grade fever | 30 |
cranial nerve | 30 |
complex care | 30 |
vaccination status | 30 |
one virus | 30 |
gene encoding | 30 |
sample collection | 30 |
children include | 30 |
quality improvement | 30 |
early years | 30 |
oral rehydration | 30 |
poor self | 30 |
also known | 30 |
observational cohort | 30 |
first weeks | 30 |
underlying conditions | 30 |
inflammatory cytokines | 30 |
available evidence | 30 |
million people | 30 |
ethical approval | 30 |
screen use | 30 |
causative agent | 30 |
epidemiological studies | 30 |
also present | 30 |
hla class | 30 |
communicable diseases | 30 |
early infancy | 30 |
relatively small | 30 |
particularly important | 30 |
viruses detected | 30 |
specific treatment | 30 |
treatment may | 30 |
south america | 30 |
seven days | 30 |
hematology oncology | 30 |
remains controversial | 30 |
persistent asthma | 30 |
psychological problems | 30 |
disordered breathing | 30 |
moral reasoning | 30 |
airway resistance | 30 |
infections may | 30 |
remained stable | 30 |
square test | 30 |
grade vur | 30 |
health policy | 30 |
school activities | 29 |
secondary attack | 29 |
mental retardation | 29 |
patient developed | 29 |
lung ultrasound | 29 |
hematologic malignancies | 29 |
adc values | 29 |
relative risk | 29 |
regression analyses | 29 |
scarlet fever | 29 |
rheumatic fever | 29 |
cell counts | 29 |
therapy may | 29 |
monoclonal antibodies | 29 |
examination revealed | 29 |
specific antibodies | 29 |
organ dysfunction | 29 |
health interventions | 29 |
early treatment | 29 |
four years | 29 |
unique teaching | 29 |
education level | 29 |
thoracic spine | 29 |
highly sensitive | 29 |
five children | 29 |
reverse transcription | 29 |
mechanically ventilated | 29 |
less commonly | 29 |
qualitative study | 29 |
findings may | 29 |
school performance | 29 |
usually occurs | 29 |
side effect | 29 |
children suffering | 29 |
longitudinal studies | 29 |
life expectancy | 29 |
symptoms may | 29 |
million children | 29 |
diagnostic value | 29 |
antimicrobial susceptibility | 29 |
diagnostic tool | 29 |
patient care | 29 |
alcohol use | 29 |
low income | 29 |
acute pyelonephritis | 29 |
congenital anomalies | 29 |
educational content | 29 |
likely due | 29 |
samples collected | 29 |
complete resolution | 29 |
nasopharyngeal aspirate | 29 |
also associated | 29 |
significant number | 29 |
approximately one | 29 |
posttraumatic stress | 29 |
virus type | 29 |
note springer | 29 |
clinical assessment | 29 |
positive children | 29 |
tumor necrosis | 29 |
index case | 29 |
airway disease | 29 |
best practices | 29 |
transcription factor | 29 |
regression models | 29 |
lactate dehydrogenase | 29 |
rhinovirus infection | 29 |
pneumococcal vaccine | 29 |
study shows | 29 |
junior high | 29 |
ciliary dyskinesia | 29 |
image gently | 29 |
refl exes | 29 |
residential care | 29 |
acute chest | 29 |
slightly higher | 29 |
public policy | 29 |
normal levels | 29 |
respiratory function | 29 |
urine output | 29 |
epidemiological characteristics | 29 |
age distribution | 28 |
mild symptoms | 28 |
first report | 28 |
universal two | 28 |
review board | 28 |
hubei province | 28 |
overall mortality | 28 |
published data | 28 |
confirmed covid | 28 |
seven children | 28 |
optic nerve | 28 |
renal ultrasound | 28 |
lower extremity | 28 |
continuous positive | 28 |
determined using | 28 |
minimal change | 28 |
rank test | 28 |
data indicate | 28 |
successfully treated | 28 |
examination showed | 28 |
treatment strategies | 28 |
maternal mental | 28 |
children affected | 28 |
hospital medical | 28 |
iron deficiency | 28 |
preliminary data | 28 |
one side | 28 |
lung abscess | 28 |
last follow | 28 |
chronic inflammation | 28 |
observational studies | 28 |
immune cells | 28 |
underlying diseases | 28 |
national survey | 28 |
clinical relevance | 28 |
clinical disease | 28 |
broad spectrum | 28 |
interstitial fibrosis | 28 |
mri showed | 28 |
feeding practices | 28 |
post transplant | 28 |
microscopic hematuria | 28 |
substance abuse | 28 |
healthy individuals | 28 |
gi tract | 28 |
home environment | 28 |
homeland security | 28 |
among pediatric | 28 |
considered significant | 28 |
clinical study | 28 |
different countries | 28 |
natural killer | 28 |
days later | 28 |
independently associated | 28 |
healthy control | 28 |
nasal cannula | 28 |
skin prick | 28 |
two main | 28 |
grade i | 28 |
whole blood | 28 |
primary education | 28 |
care professionals | 28 |
randomly selected | 28 |
associated factors | 28 |
mass casualty | 28 |
secondary school | 28 |
vaccine development | 28 |
within weeks | 28 |
child behavior | 28 |
young patients | 28 |
rhinovirus genome | 28 |
social justice | 28 |
signal intensity | 28 |
times per | 28 |
sustainable development | 28 |
available data | 28 |
based approach | 28 |
cardiac arrest | 28 |
studies show | 28 |
serum ige | 28 |
treatment modalities | 28 |
virulence factors | 28 |
positive predictive | 28 |
disease among | 28 |
among child | 28 |
paid paternity | 28 |
central role | 28 |
significantly less | 28 |
asymptomatic patients | 28 |
family functioning | 27 |
commonly associated | 27 |
new cases | 27 |
small airways | 27 |
natural disasters | 27 |
best practice | 27 |
liver enzymes | 27 |
factors influencing | 27 |
case management | 27 |
antibody titers | 27 |
three weeks | 27 |
neurological symptoms | 27 |
additional information | 27 |
pneumonia mar | 27 |
infants aged | 27 |
reading comprehension | 27 |
immune deficiency | 27 |
readily available | 27 |
facial nerve | 27 |
pediatr doi | 27 |
elevated levels | 27 |
higher rate | 27 |
function testing | 27 |
san francisco | 27 |
low grade | 27 |
three studies | 27 |
pleural fl | 27 |
study reported | 27 |
social capital | 27 |
maintenance therapy | 27 |
clinical suspicion | 27 |
severe symptoms | 27 |
mg ml | 27 |
pediatric hospital | 27 |
virus disease | 27 |
particular attention | 27 |
cognitive flexibility | 27 |
newborn infants | 27 |
clinical status | 27 |
patient characteristics | 27 |
contrast enhanced | 27 |
patient presented | 27 |
infected infants | 27 |
children exposed | 27 |
pneumonia may | 27 |
normal controls | 27 |
igg levels | 27 |
fl ow | 27 |
chest syndrome | 27 |
older patients | 27 |
beneficial effects | 27 |
protein levels | 27 |
healthcare system | 27 |
cell histiocytosis | 27 |
infections due | 27 |
stage ii | 27 |
studies using | 27 |
next generation | 27 |
family income | 27 |
generation sequencing | 27 |
ethnic differences | 27 |
oral prednisone | 27 |
independent risk | 27 |
disseminated intravascular | 27 |
physical therapy | 27 |
surgical treatment | 27 |
human rotavirus | 27 |
treatment failure | 27 |
information regarding | 27 |
cases reported | 27 |
mast cells | 27 |
antiviral agents | 27 |
symptom onset | 27 |
lower risk | 27 |
cell activation | 27 |
resolution ct | 27 |
competing interests | 27 |
three cases | 27 |
marrow failure | 27 |
medication use | 27 |
risk groups | 27 |
increased incidence | 27 |
missing data | 27 |
family violence | 27 |
cell cycle | 27 |
food system | 27 |
fever without | 27 |
medical university | 27 |
herpes simplex | 27 |
routine use | 27 |
psychological effects | 27 |
cardiac disease | 27 |
nonalcoholic fatty | 27 |
yellow fever | 27 |
increasing number | 27 |
nephrotic range | 27 |
based interventions | 27 |
transmission rates | 27 |
yersinia enterocolitica | 27 |
eosinophil count | 27 |
active shooter | 27 |
significant change | 27 |
factors affecting | 26 |
commonly seen | 26 |
involving children | 26 |
past year | 26 |
risk patients | 26 |
respiratory complications | 26 |
commonly encountered | 26 |
parental alcohol | 26 |
high proportion | 26 |
may persist | 26 |
positive patients | 26 |
necrosis factor | 26 |
parental leave | 26 |
several factors | 26 |
positive effect | 26 |
dietary diversity | 26 |
wall thickening | 26 |
sensorineural hearing | 26 |
food consumption | 26 |
type ii | 26 |
liver transplantation | 26 |
nutritional support | 26 |
national institute | 26 |
pediatric radiologist | 26 |
primary infection | 26 |
western australia | 26 |
viral causes | 26 |
fold higher | 26 |
observed among | 26 |
patients will | 26 |
induced sputum | 26 |
severe croup | 26 |
large numbers | 26 |
picu admission | 26 |
cardiovascular risk | 26 |
girl presented | 26 |
middle school | 26 |
chronic pulmonary | 26 |
technology dependent | 26 |
hospital discharge | 26 |
combination therapy | 26 |
rare disease | 26 |
two doses | 26 |
african children | 26 |
term outcomes | 26 |
immunosuppressive therapy | 26 |
hand washing | 26 |
caregiver burden | 26 |
several weeks | 26 |
organ systems | 26 |
street youth | 26 |
matched controls | 26 |
respiratory morbidity | 26 |
rsv infections | 26 |
cross sectional | 26 |
adjusted odds | 26 |
primary immunodeficiencies | 26 |
irb approval | 26 |
pediatric practice | 26 |
definitive diagnosis | 26 |
chlamydia pneumoniae | 26 |
abusive head | 26 |
elevated serum | 26 |
final manuscript | 26 |
assessment tool | 26 |
traumatic brain | 26 |
rare cases | 26 |
ct angiography | 26 |
studies included | 26 |
qualitative data | 26 |
early recognition | 26 |
beneficial effect | 26 |
limited number | 26 |
fatality rate | 26 |
action sequences | 26 |
interstitial nephritis | 26 |
advisory committee | 26 |
lessons learned | 26 |
interventional radiology | 26 |
physical exam | 26 |
develop severe | 26 |
external rotation | 26 |
blood tests | 25 |
urban poor | 25 |
safety profile | 25 |
active disease | 25 |
epidemiological study | 25 |
implemented interventions | 25 |
child anxiety | 25 |
migrant children | 25 |
metastatic disease | 25 |
alkaline phosphatase | 25 |
absolute neutrophil | 25 |
health disparities | 25 |
membrane oxygenation | 25 |
neurological complications | 25 |
atopic children | 25 |
first two | 25 |
potential role | 25 |
parental education | 25 |
antiretroviral therapy | 25 |
current pandemic | 25 |
pneumonia caused | 25 |
also provide | 25 |
cell line | 25 |
important risk | 25 |
gene therapy | 25 |
ejection fraction | 25 |
anxiety symptoms | 25 |
remaining patients | 25 |
within normal | 25 |
enrolled children | 25 |
associated complications | 25 |
infectious complications | 25 |
systemic lupus | 25 |
children need | 25 |
factor viii | 25 |
health emergency | 25 |
female ratio | 25 |
allergic asthma | 25 |
measles vaccines | 25 |
cholera toxin | 25 |
autoimmune disease | 25 |
pulmonary edema | 25 |
studies involving | 25 |
creatinine level | 25 |
severely affected | 25 |
many parents | 25 |
femoral head | 25 |
none declared | 25 |
infants less | 25 |
stool cultures | 25 |
might also | 25 |
living conditions | 25 |
family well | 25 |
technology dependence | 25 |
vascular resistance | 25 |
will focus | 25 |
host factors | 25 |
infected patients | 25 |
key words | 25 |
gender differences | 25 |
ten patients | 25 |
attention deficit | 25 |
developing world | 25 |
will allow | 25 |
several limitations | 25 |
aboriginal children | 25 |
kg min | 25 |
pictorial review | 25 |
ductus arteriosus | 25 |
eastern europe | 25 |
relapse rate | 25 |
including covid | 25 |
virus bronchiolitis | 25 |
generation cephalosporin | 25 |
organ transplantation | 25 |
risk group | 25 |
may reveal | 25 |
diagnostic imaging | 25 |
tidal volume | 25 |
may produce | 25 |
ewing sarcoma | 25 |
global pandemic | 25 |
annual attack | 25 |
also included | 25 |
become infected | 25 |
indirect principles | 25 |
study provides | 25 |
angiotensin converting | 25 |
inflammatory cells | 24 |
underlying medical | 24 |
household members | 24 |
steroid resistant | 24 |
generalized anxiety | 24 |
clinical information | 24 |
poor feeding | 24 |
pcr testing | 24 |
days post | 24 |
adverse effect | 24 |
participants will | 24 |
urine protein | 24 |
continuous variables | 24 |
stage iii | 24 |
moral sensitivity | 24 |
preventive measures | 24 |
flow nasal | 24 |
negatively associated | 24 |
since birth | 24 |
total score | 24 |
metabolic alkalosis | 24 |
influenza vaccines | 24 |
local community | 24 |
free survival | 24 |
surgical management | 24 |
economic status | 24 |
coronavirus pneumonia | 24 |
paediatric neurology | 24 |
general anesthesia | 24 |
last decade | 24 |
febrile illness | 24 |
jia patients | 24 |
children patients | 24 |
dent disease | 24 |
blood vessels | 24 |
viral illness | 24 |
household size | 24 |
may demonstrate | 24 |
higher scores | 24 |
chronic wet | 24 |
early stages | 24 |
oral prednisolone | 24 |
national center | 24 |
negative effects | 24 |
high quality | 24 |
may decrease | 24 |
body surface | 24 |
coronavirus pandemic | 24 |
adenovirus infection | 24 |
prenatal diagnosis | 24 |
csa treatment | 24 |
healthy subjects | 24 |
tubular epithelial | 24 |
currently available | 24 |
life threatening | 24 |
necrotizing enterocolitis | 24 |
clinical conditions | 24 |
digital media | 24 |
serious adverse | 24 |
first study | 24 |
following criteria | 24 |
higher education | 24 |
prospective observational | 24 |
milder cases | 24 |
spectrum antibiotics | 24 |
study results | 24 |
paediatric renal | 24 |
higher among | 24 |
first step | 24 |
european society | 24 |
accurate diagnosis | 24 |
clinical manifestation | 24 |
pediatric pneumonia | 24 |
began shooting | 24 |
day course | 24 |
may experience | 24 |
surgical intervention | 24 |
febrile uti | 24 |
term infants | 24 |
viral detection | 24 |
welfare institute | 24 |
past months | 24 |
significantly improved | 24 |
maternal smoking | 24 |
previously published | 24 |
art para | 24 |
idiopathic nephrotic | 24 |
newborn infant | 24 |
based intervention | 24 |
respiratory health | 24 |
control medication | 24 |
general practitioner | 24 |
infect dis | 24 |
atopic sensitization | 24 |
breath sounds | 24 |
blood loss | 24 |
take place | 24 |
groups according | 24 |
growth hormone | 24 |
relatively common | 24 |
month follow | 24 |
collected data | 24 |
diffusion restriction | 24 |
frequently detected | 24 |
usually present | 24 |
significantly correlated | 23 |
slit diaphragm | 23 |
aldrich syndrome | 23 |
china objective | 23 |
common complication | 23 |
problem solving | 23 |
igg antibodies | 23 |
blood transfusions | 23 |
antibody levels | 23 |
patient outcomes | 23 |
highest risk | 23 |
first reported | 23 |
outcome measure | 23 |
whole exome | 23 |
identify patients | 23 |
missense mutation | 23 |
three days | 23 |
clinical evidence | 23 |
hbov infection | 23 |
infantile colic | 23 |
study demonstrated | 23 |
dental care | 23 |
serious infections | 23 |
renal artery | 23 |
health risk | 23 |
myofascial structures | 23 |
cardiopulmonary bypass | 23 |
frequently used | 23 |
bone age | 23 |
often seen | 23 |
runny nose | 23 |
prevalence rates | 23 |
primary disease | 23 |
single centre | 23 |
mortality among | 23 |
life satisfaction | 23 |
salmonella infection | 23 |
resource allocation | 23 |
severe influenza | 23 |
care programs | 23 |
invasive ventilation | 23 |
lung volume | 23 |
lower limbs | 23 |
enteric pathogens | 23 |
inflammatory mediators | 23 |
graft loss | 23 |
disease associated | 23 |
without significant | 23 |
fi ssure | 23 |
patient survival | 23 |
nephritic syndrome | 23 |
cancer therapy | 23 |
cns involvement | 23 |
vulnerable populations | 23 |
indian children | 23 |
ground glass | 23 |
successful treatment | 23 |
soft tissues | 23 |
statistical difference | 23 |
vena cava | 23 |
success rate | 23 |
significant role | 23 |
concentrated disadvantage | 23 |
consecutive days | 23 |
nasal secretions | 23 |
flow rate | 23 |
intracranial pressure | 23 |
lung tissue | 23 |
campylobacter enteritis | 23 |
main cause | 23 |
pulmonary involvement | 23 |
bacterial causes | 23 |
focus groups | 23 |
first three | 23 |
also identified | 23 |
weighted images | 23 |
increased severity | 23 |
wilcoxon rank | 23 |
oral intake | 23 |
study used | 23 |
almost always | 23 |
mcg kg | 23 |
urinary excretion | 23 |
molecular epidemiology | 23 |
nearly half | 23 |
retrospective case | 23 |
basal ganglia | 23 |
among others | 23 |
common pediatric | 23 |
high morbidity | 23 |
people living | 23 |
failure due | 23 |
warning signs | 23 |
proximal tubular | 23 |
protein expression | 23 |
influenza surveillance | 23 |
much lower | 23 |
radiographic features | 23 |
care settings | 23 |
children often | 23 |
limited access | 23 |
recently published | 23 |
child will | 23 |
nasogastric tube | 23 |
two days | 23 |
vaccinated children | 23 |
asymptomatic infections | 23 |
via telehealth | 23 |
multidisciplinary team | 23 |
perceived control | 23 |
infants may | 23 |
dairy products | 23 |
adverse reactions | 23 |
ct features | 23 |
function test | 23 |
research project | 23 |
disease characterized | 23 |
tube placement | 23 |
high degree | 23 |
wbc count | 23 |
patient group | 23 |
leukocyte count | 23 |
mean score | 23 |
risk assessment | 23 |
patient received | 23 |
serum samples | 23 |
family support | 23 |
neutropenic patients | 23 |
health risks | 23 |
household income | 23 |
ethnic groups | 23 |
healthy adults | 23 |
safecare providers | 23 |
prognostic factors | 23 |
prevalence rate | 23 |
portal vein | 23 |
primary prevention | 23 |
cellular immunity | 23 |
diagnosis may | 23 |
racemic epinephrine | 23 |
children presented | 23 |
adolescent health | 22 |
evaluated using | 22 |
bone disease | 22 |
medical staff | 22 |
final diagnosis | 22 |
vaccine era | 22 |
without evidence | 22 |
improve outcomes | 22 |
urban settings | 22 |
pneumococcal colonization | 22 |
chronic inflammatory | 22 |
restricted diffusion | 22 |
may appear | 22 |
categorical variables | 22 |
health education | 22 |
molecular weight | 22 |
educational level | 22 |
old child | 22 |
may reflect | 22 |
clostridium difficile | 22 |
blood counts | 22 |
tracheobronchial tree | 22 |
also noted | 22 |
patients hospitalized | 22 |
dysfunction may | 22 |
rapid diagnosis | 22 |
national institutes | 22 |
obese patients | 22 |
cancer patients | 22 |
skin lesions | 22 |
term prognosis | 22 |
may vary | 22 |
th cells | 22 |
extracorporeal membrane | 22 |
term consequences | 22 |
progressive renal | 22 |
especially important | 22 |
host defense | 22 |
immunocompromised host | 22 |
rna viruses | 22 |
normal children | 22 |
atopic eczema | 22 |
american indian | 22 |
vascular access | 22 |
hiv disease | 22 |
least days | 22 |
hospital length | 22 |
although children | 22 |
staff members | 22 |
may indicate | 22 |
general hospital | 22 |
three age | 22 |
developing asthma | 22 |
eight children | 22 |
clinical use | 22 |
congestive heart | 22 |
one another | 22 |
nasolacrimal duct | 22 |
throat swabs | 22 |
prick test | 22 |
lower limb | 22 |
commonly reported | 22 |
cape town | 22 |
rare case | 22 |
cd count | 22 |
communityacquired pneumonia | 22 |
scoring system | 22 |
endotoxin exposure | 22 |
every year | 22 |
mortality due | 22 |
laboratory investigations | 22 |
clinically relevant | 22 |
data available | 22 |
parenting self | 22 |
tyrosine kinase | 22 |
psychological maltreatment | 22 |
may influence | 22 |
common viral | 22 |
atopic disease | 22 |
clinical experience | 22 |
academic performance | 22 |
home visiting | 22 |
lateral wall | 22 |
eustachian tube | 22 |
smoke exposure | 22 |
findings indicate | 22 |
np carriage | 22 |
atypical pneumonia | 22 |
therapeutic strategies | 22 |
dose reduction | 22 |
proinflammatory cytokines | 22 |
systemic symptoms | 22 |
overall prevalence | 22 |
compound heterozygous | 22 |
lower incidence | 22 |
rating scale | 22 |
distress among | 22 |
pediatric health | 22 |
venous blood | 22 |
factors including | 22 |
detection rate | 22 |
child marriage | 22 |
kidney diseases | 22 |
immunodeficiency syndrome | 22 |
post mortem | 22 |
developmental conditions | 22 |
one item | 22 |
health consequences | 22 |
pediatric acute | 22 |
protein intake | 22 |
southeast asia | 22 |
may suggest | 22 |
dressing changes | 22 |
unclear whether | 22 |
immune reconstitution | 22 |
health study | 22 |
must also | 22 |
increased mortality | 22 |
tubular cells | 22 |
exclusive breastfeeding | 22 |
protection services | 22 |
latex agglutination | 22 |
schwartz formula | 22 |
calculated using | 22 |
pediatric palliative | 22 |
patients required | 22 |
roc curve | 22 |
care delivery | 22 |
acute onset | 22 |
cell differentiation | 22 |
convalescent plasma | 22 |
clinical research | 22 |
past decade | 22 |
medical college | 22 |
weeks later | 22 |
cytokine production | 22 |
us children | 22 |
positive parenting | 22 |
inner ear | 22 |
negative consequences | 22 |
glass opacities | 22 |
controlled studies | 22 |
intellectual disability | 22 |
care provider | 22 |
lung symptoms | 22 |
neonates born | 22 |
airway responsiveness | 22 |
innate immunity | 22 |
cigarette smoke | 22 |
will review | 22 |
dendritic cells | 22 |
late effects | 22 |
igg subclass | 22 |
enteric infections | 22 |
physically abused | 21 |
high index | 21 |
antibiotic prophylaxis | 21 |
serum ferritin | 21 |
acute upper | 21 |
statistical analyses | 21 |
case definition | 21 |
screening tool | 21 |
antisocial behavior | 21 |
insulin resistance | 21 |
purpura nephritis | 21 |
specific igg | 21 |
iu ml | 21 |
productive cough | 21 |
bacterial pathogen | 21 |
study protocol | 21 |
adaptive immune | 21 |
young febrile | 21 |
severe diarrhea | 21 |
time spent | 21 |
bone mineral | 21 |
kg hr | 21 |
common clinical | 21 |
children might | 21 |
generation cephalosporins | 21 |
treated patients | 21 |
psychiatric disorders | 21 |
per million | 21 |
four studies | 21 |
approximately half | 21 |
cells mm | 21 |
osteopathic procedures | 21 |
idiopathic pulmonary | 21 |
helicobacter pylori | 21 |
mouse model | 21 |
younger patients | 21 |
viral coinfection | 21 |
oncology group | 21 |
infl uenzae | 21 |
assess whether | 21 |
increased prevalence | 21 |
american children | 21 |
policy documents | 21 |
health sector | 21 |
troublesome lung | 21 |
suspected cases | 21 |
significantly better | 21 |
related mortality | 21 |
infection caused | 21 |
mean number | 21 |
four groups | 21 |
based studies | 21 |
indirect effects | 21 |
healthy volunteers | 21 |
social determinants | 21 |
demographic information | 21 |
mean value | 21 |
immunodefi ciency | 21 |
pediatric asthma | 21 |
increased expression | 21 |
severe course | 21 |
appropriate therapy | 21 |